Hong Kong Cytology Tutorial 2023

Dr. Baloch received his medical degree from Liaquat Medical University in Sind, Pakistan. After receiving his PhD in 1991 he joined the pathology residency at Hahnemann University Hospital. This was followed by fellowships in surgical pathology at Memorial Sloan Kettering Cancer Center, New York and cytopathology at the University of Pennsylvania Medical Center, Philadelphia. Dr. Baloch began his career as an assistant professor in the Department of Pathology & Laboratory Medicine at UPENN medical center in1997 and is currently a professor of pathology and laboratory medicine there. He has authored more than 200 peer reviewed publications in leading pathology journals on the subject of endocrine and head and neck pathology; and book chapters and monographs. Dr. Baloch has delivered numerous lectures, workshops and short courses both at the national and international meetings including ASC, USCAP, ASCP, CAP, ECC and IAP. Dr. Baloch has co-authored 3 books and has served as co-editor of the most recent ?Milan System for Reporting Salivary Gland Cytopathology?. Dr. Baloch has also served as the chair of the terminology and morphologic criteria committee of the 2007 NCI sponsored thyroid FNA initiative which led to the development of ?Bethesda Thyroid FNA Classification Scheme?. Dr. Baloch also served on the international panel which recommended the renaming of encapsulated follicular variant of papillary thyroid carcinoma to non-invasive follicular tumor with papillary like nuclear features (NIFTP). Dr. Baloch is executive editor of Diagnostic Cytopathology and member of the editorial board of Cancer Cytopathology, Cytojournal, Endocrine Pathology and Journal of American Society of Cytopathology.

Dr. Baloch has served as the chair of ASCP and ASC annual meeting scientific program committee, member of USCAP education committee, ASC executive board, ASCP committee for continuing professional development, Papanicolaou Society scientific program committee, American Association of Endocrinologist thyroid nodule guideline task force and American Thyroid Association laboratory test committee.

Dr Ashish Chandra MD FRCPath DipRCPath (Cytol), MIAC, Vice-President IAC, Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom. He is a co-editor of the International system for reporting serous fluid cytopathology and is a contributor to other terminology systems and clinical guidelines. His interests include FNA, ROSE and genito-urinary histopathology.

Professor Fernando Schmitt is a Professor of Pathology at the Medical Faculty of University of Porto, Senior Researcher and Head of Molecular Pathology Unit at IPATIMUP, Director of RISE (Clinical and Translational Research Network of the Medical Faculty), Past-President of the International Society of Breast Pathology and President of the International Academy of Cytology (IAC). He has authored over 500 papers in peer-reviewed journals, 33 book chapters, and is the editor of six books. Prof Schmitt is widely considered a world-leading expert in cytopathology and breast cancer. Fernando was a fellow at the Karolinska Medical Hospital, Stockholm, and was a Professor of Pathology at the University of São Paulo (USP), Brazil, and University of Toronto, Canada. He was also Director of the Department of Medicine at Laboratoire national de Santé, Luxembourg. His research work is on breast cancer, with emphasis on molecular markers, cell adhesion and invasion, therapeutic targets, and mechanisms of resistance. In the last years, his research work has been dedicated to the study of molecular markers on cytological material. Fernando serves as Editor in Chief of Pathobiology and Associate Editor of six major scientific journals and sits on the editorial board of many others. He is a standing member of the WHO-IAC Classification of Tumours. He has also been chair, president, or scientific director of several major European, Portuguese, and Brazilian scientific societies of pathology and cytology. He received the following prizes: Educator of the Year 2011 by the PSC, GOLDBLATT AWARD 2013 by the IAC, Dario Cruz 2018 from the Portuguese League Against Cancer for his career as a researcher in breast cancer, and the 2021 International Achievement Award from the American Society of Cytopathology.